Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 2/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.33 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5685588 | 0.88 | — | — | |
| SCHEMBL20288 | 0.85 | RECQL (0.53) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL5961699 | 0.85 | RECQL (0.53) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL1578245 | 0.84 | RECQL (0.35) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL61178 | 0.84 | FUT7 (0.33) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL5961715 | 0.83 | RECQL (0.53) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL5961714 | 0.83 | RECQL (0.53) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL2453688 | 0.83 | RECQL (0.53) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL5961710 | 0.83 | RECQL (0.53) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL3649647 | 0.82 | RECQL (0.40) | RECQLGLAHPGDTSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022246027-A1 | ELECTROCHROMIC MATERIALS; PREPARATION AND USE THEREOF | UNIVERSITY OF CONNECTICUT (US) | 2022-11-24 | — | — | WO | claimed |
| US-20160264925-A1 | Reagents for Lysis of Bacterial Cells | ROCHE DIAGNOSTICS GMBH (DE) | 2016-09-15 | — | — | US | claimed |
| EP-1869061-A2 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | Combimatrix Corporation (US) | 2007-12-26 | — | — | EP | claimed |
| EP-1836471-A2 | HIGH TEMPERATURE TISSUE CONDITIONING WITH LOW VOLATILITY SOLUTIONS AND APPLICATIONS | VENTANA MEDICAL SYSTEMS, INC. (US) | 2007-09-26 | — | — | EP | claimed |
| EP-1805206-A2 | ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE | Combimatrix Corporation (US) | 2007-07-11 | — | — | EP | claimed |
| WO-2006105037-A2 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | COMBIMATRIX CORPORATION (US) | 2006-10-05 | — | — | WO | claimed |
| WO-2006094052-A2 | GEL POLYMER ELECTROLYTES | TRITON SYSTEMS, INC. (US) | 2006-09-08 | — | — | WO | claimed |
| WO-2006066039-A2 | HIGH TEMPERATURE TISSUE CONDITIONING WITH LOW VOLATILITY SOLUTIONS AND APPLICATIONS | KRAM BRIAN H (US) | 2006-06-22 | — | — | WO | claimed |
| WO-2006031814-A2 | ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE | COMBIMATRIX CORPORATION (US) | 2006-03-23 | — | — | WO | claimed |
| EP-3229959-A1 | HIGH EFFICIENCY, SMALL VOLUME NUCLEIC ACID SYNTHESIS | Life Technologies Corporation (US) | 2017-10-18 | — | — | EP | disclosed |
| WO-2016094512-A1 | HIGH EFFICIENCY, SMALL VOLUME NUCLEIC ACID SYNTHESIS | yLIFE TECHNOLOGIES CORPORATION (US) | 2016-06-16 | — | — | WO | disclosed |
| WO-2013036789-A1 | ELECTROCHROMIC DEVICES PREPARED FROM THE IN SITU FORMATION OF CONJUGATED POLYMERS | UNIVERSITY OF CONNECTICUT (US) | 2013-03-14 | — | — | WO | disclosed |
| EP-2550557-A2 | FORMATION OF CONJUGATED POLYMERS FOR SOLID-STATE DEVICES | University of Connecticut (US) | 2013-01-30 | — | — | EP | disclosed |
| EP-2512492-A1 | METHODS OF INHIBITING CATARACTS AND PRESBYOPIA | University of Massachusetts (US) | 2012-10-24 | — | — | EP | disclosed |
| US-20080045723-A1 | Method of preparation of halogen-free ionic liquids and ionic liquids prepared in this manner | PETROLEO BRASILEIRO S.A. - PETROBRAS (BR) | 2008-02-21 | — | — | US | disclosed |
| EP-1869061-A2 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | Combimatrix Corporation (US) | 2007-12-26 | — | — | EP | disclosed |
| EP-1805206-A2 | ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE | Combimatrix Corporation (US) | 2007-07-11 | — | — | EP | disclosed |
| WO-2006105037-A2 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | COMBIMATRIX CORPORATION (US) | 2006-10-05 | — | — | WO | disclosed |
| WO-2006094052-A2 | GEL POLYMER ELECTROLYTES | TRITON SYSTEMS, INC. (US) | 2006-09-08 | — | — | WO | disclosed |
| WO-2006031814-A2 | ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE | COMBIMATRIX CORPORATION (US) | 2006-03-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080045723-A1 | Method of preparation of halogen-free ionic liquids and ionic liquids prepared in this manner | AFF4, AFF2, HCN3 | RECQL 4030/4885GLA 4742/4885HPGD 4829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.